Catalyst Pharmaceutical
CPRX
CPRX
105 hedge funds and large institutions have $219M invested in Catalyst Pharmaceutical in 2017 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 30 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12.6% more ownership
Funds ownership: 42.11% → 54.7% (+13%)
16% less call options, than puts
Call options by funds: $108K | Put options by funds: $128K
Holders
105
Holding in Top 10
1
Calls
$108K
Puts
$128K
Top Buyers
| 1 | +$16M | |
| 2 | +$14.9M | |
| 3 | +$8.08M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$5.36M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.81M |
Top Sellers
| 1 | -$2.91M | |
| 2 | -$1.45M | |
| 3 | -$1.41M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.21M |
| 5 |
JPMorgan Chase & Co
New York
|
-$323K |